Literature DB >> 6687220

Hemocytopenia as initial manifestation of systemic lupus erythematosus. Prognostic significance.

C Lavalle, R Hurtado, J J Quezada, A Cabral, A Fraga.   

Abstract

In 1960 Rabinowitz and Dameshek emphasized the close relationship between idiopathic thrombocytopenic purpura (ITP) and systemic lupus erythematosus (SLE) and suggested that ITP is often a prodrome of SLE. On the basis of tis observation, the present study was designed to investigate the prevalence of SLE in patients with the initial diagnosis of ITP, autoimmune hemolytic anemia (AIHA), Fisher-Evans' syndrome (F-E) and idiopathic aplastic bone marrow (IABM) and to investigate the salient clinical manifestations and prognosis of these patients. We studied 62 patients, 35 with ITP, 16 with AIHA, 9 with F-E and 2 with IABM. Seventeen developed four or more ARA criteria for SLE within 6 of 14 years after the initial hematologic manfestations (IHM). Mucocutaneous symptoms predominated in all groups. None developed renal failure and only 2 had central nervous system involvement. When these patients were matched by age, sex and duration of illness with 24 SLE patients without hematologic abnormalities, the everity and therapeutic indices of the former showed a significantly (p 0.001) milder course. Eight of the 9 patients that required splenectomy are at present without treatment. SLE patient with IHM have a more benign course which is not worsened by splenectomy.

Entities:  

Mesh:

Year:  1983        PMID: 6687220     DOI: 10.1007/bf02041395

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

Review 1.  Immune haemolytic disease: the autoimmune haemolytic anaemias.

Authors:  B Pirofsky
Journal:  Clin Haematol       Date:  1975-02

2.  Systemic lupus erytematosus after "idiopathic" thrombocytopenic purpura: a review.

Authors:  Y RABINOWITZ; W DAMESHEK
Journal:  Ann Intern Med       Date:  1960-01       Impact factor: 25.391

3.  Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases.

Authors:  A M HARVEY; L E SHULMAN; P A TUMULTY; C L CONLEY; E H SCHOENRICH
Journal:  Medicine (Baltimore)       Date:  1954-12       Impact factor: 1.889

Review 4.  Autoimmune hemolytic anemia. II. Therapeutic aspects.

Authors:  B Pirofsky; E J Bardana
Journal:  Ser Haematol       Date:  1974

5.  Anti-DNA antibodies by the Farr and the Crithidia luciliae assays and the clinical status of systemic lupus erythematosus.

Authors:  C Lavalle; A Núñez; E Muñoz
Journal:  Rev Invest Clin       Date:  1981 Oct-Dec       Impact factor: 1.451

6.  Clinical subset of systemic lupus erythematosus.

Authors:  P A Reyes; C Lavalle
Journal:  Arthritis Rheum       Date:  1980-09

7.  Membranous lupus nephropathy: a clinicopathologic study.

Authors:  J V Donadio; J H Burgess; K E Holley
Journal:  Medicine (Baltimore)       Date:  1977-11       Impact factor: 1.889

8.  A study of thrombocytopenia. New histologic criteria for the differentiation of idiopathic thrombocytopenia and thrombocytopenia associated with disseminated lupus erythematosus.

Authors:  R T Breckenridge; R D Moore; O D Ratnoff
Journal:  Blood       Date:  1967-07       Impact factor: 22.113

9.  Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen.

Authors:  D M Winn; J F Wolfe; D A Lindberg; F H Fristoe; L Kingsland; G C Sharp
Journal:  Arthritis Rheum       Date:  1979-12

Review 10.  Immunologic precursors of autoimmune hematologic disorders. Autoimmune hematologic disorders. Autoimmune hemolytic anemia and thrombocytopenic purpura.

Authors:  C L Conley
Journal:  Johns Hopkins Med J       Date:  1981-09
View more
  5 in total

1.  Efficacy and safety of laparoscopic splenectomy in thrombocytopenia secondary to systemic lupus erythematosus.

Authors:  Jin Zhou; Zhong Wu; Zongguang Zhou; Zhiqiang Wang; Yi Liu; Xiang-Yang Huang; Bing Peng
Journal:  Clin Rheumatol       Date:  2013-04-03       Impact factor: 2.980

2.  Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus.

Authors:  Y Nancy You; Ayalew Tefferi; David M Nagorney
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

3.  Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort.

Authors:  Sergio Durán; Mandar Apte; Graciela S Alarcón; Miranda C Marion; Jeffrey C Edberg; Robert P Kimberly; Jie Zhang; Carl D Langefeld; Luis M Vilá; John D Reveille
Journal:  Arthritis Rheum       Date:  2008-09-15

4.  Impact of autoimmune cytopenias on severity of childhood-onset systemic lupus erythematosus: A single-center retrospective cohort study.

Authors:  Ekemini A Ogbu; Shanmuganathan Chandrakasan; Kelly Rouster-Stevens; Larry A Greenbaum; Ignacio Sanz; Scott E Gillespie; Chelsea Marion; Karli Okeson; Sampath Prahalad
Journal:  Lupus       Date:  2020-10-27       Impact factor: 2.911

5.  Experience with Evans syndrome in an academic referral center.

Authors:  José Carlos Jaime-Pérez; Liliana Nataly Guerra-Leal; Olga Nidia López-Razo; Nereida Méndez-Ramírez; David Gómez-Almaguer
Journal:  Rev Bras Hematol Hemoter       Date:  2015-03-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.